Walleye Trading’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-14,079
| Closed | -$558K | – | 1744 |
|
|
2023
Q4 | $558K | Buy |
14,079
+5,749
| +69% | +$228K | ﹤0.01% | 781 |
|
|
2023
Q3 | $229K | Sell |
8,330
-208
| -2% | -$5.72K | ﹤0.01% | 944 |
|
|
2023
Q2 | $290K | Buy |
+8,538
| New | +$290K | ﹤0.01% | 708 |
|
|
2023
Q1 | – | Sell |
-2,153
| Closed | -$96K | – | 1716 |
|
|
2022
Q4 | $96K | Sell |
2,153
-14,590
| -87% | -$650K | ﹤0.01% | 1168 |
|
|
2022
Q3 | $471K | Buy |
16,743
+3,832
| +30% | +$108K | ﹤0.01% | 763 |
|
|
2022
Q2 | $348K | Buy |
12,911
+5,224
| +68% | +$141K | ﹤0.01% | 943 |
|
|
2022
Q1 | $262K | Buy |
+7,687
| New | +$262K | ﹤0.01% | 1042 |
|
|
2021
Q4 | – | Sell |
-3,518
| Closed | -$190K | – | 2094 |
|
|
2021
Q3 | $190K | Buy |
+3,518
| New | +$190K | ﹤0.01% | 1099 |
|
|
2020
Q3 | – | Sell |
-5,714
| Closed | -$74K | – | 1194 |
|
|
2020
Q2 | $74K | Buy |
+5,714
| New | +$74K | ﹤0.01% | 898 |
|
|
2018
Q4 | – | Sell |
-3
| Closed | – | – | 1508 |
|
|
2018
Q3 | $0 | Buy |
+3
| New | – | ﹤0.01% | 1843 |
|
|
2017
Q3 | – | Sell |
-3
| Closed | – | – | 1194 |
|
|
2017
Q2 | $0 | Buy |
+3
| New | – | ﹤0.01% | 1457 |
|
|
2016
Q1 | – | Sell |
-5
| Closed | -$1K | – | 1874 |
|
|
2015
Q4 | $1K | Buy |
+5
| New | +$1K | ﹤0.01% | 1809 |
|